acc01301 |
Charged multivesicular body protein 3 |
oxidation |
Met197 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01302 |
Eukaryotic translation initiation factor 3 subunit C |
phosphorylation |
Ser13 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01303 |
Eukaryotic translation initiation factor 3 subunit C-like protein |
phosphorylation |
Ser13 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01304 |
Eukaryotic translation initiation factor 3 subunit C |
phosphorylation |
Ser15 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01305 |
Eukaryotic translation initiation factor 3 subunit C-like protein |
phosphorylation |
Ser15 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01306 |
Eukaryotic translation initiation factor 3 subunit C |
phosphorylation |
Ser181 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01307 |
Eukaryotic translation initiation factor 3 subunit C-like protein |
phosphorylation |
Ser181 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01308 |
Eukaryotic translation initiation factor 3 subunit C |
phosphorylation |
Ser182 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01309 |
Eukaryotic translation initiation factor 3 subunit C-like protein |
phosphorylation |
Ser182 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01310 |
"Nascent polypeptide-associated complex subunit alpha, muscle-specific form" |
phosphorylation |
Ser2029 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01311 |
Membrane-associated progesterone receptor component 1 |
phosphorylation |
Ser181 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01312 |
Myc box-dependent-interacting protein 1 |
phosphorylation |
Ser296 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01313 |
Myc box-dependent-interacting protein 1 |
phosphorylation |
Ser298 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01314 |
U3 small nucleolar ribonucleoprotein protein MPP10 |
phosphorylation |
Ser171 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01315 |
Nucleolar protein 56 |
phosphorylation |
Ser563 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01316 |
Histone-lysine N-methyltransferase 2D |
phosphorylation |
Ser4359 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01317 |
Na(+)/H(+) exchange regulatory cofactor NHE-RF1 |
phosphorylation |
Ser280 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01318 |
Secretory carrier-associated membrane protein 3 |
phosphorylation |
Ser76 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01319 |
Protein phosphatase 1 regulatory subunit 12A |
phosphorylation |
Ser862 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01320 |
Cyclin-G-associated kinase |
phosphorylation |
Ser829 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01321 |
Protein transport protein Sec16A |
phosphorylation |
Ser592 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01322 |
Protein transport protein Sec16A |
phosphorylation |
Ser595 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01323 |
Transcription intermediary factor 1-alpha |
phosphorylation |
Ser1028 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01324 |
Eukaryotic translation initiation factor 3 subunit D |
phosphorylation |
Ser528 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01325 |
"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2" |
phosphorylation |
Ser701 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01326 |
U4/U6 small nuclear ribonucleoprotein Prp3 |
phosphorylation |
Ser619 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01327 |
Tumor protein D54 |
phosphorylation |
Ser12 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01328 |
Forkhead box protein O3 |
phosphorylation |
Ser12 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01329 |
Density-regulated protein |
phosphorylation |
Ser73 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01330 |
17S U2 SnRNP complex component HTATSF1 |
phosphorylation |
Ser721 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01331 |
17S U2 SnRNP complex component HTATSF1 |
phosphorylation |
Ser702 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01332 |
U3 small nucleolar RNA-interacting protein 2 |
phosphorylation |
Ser50 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01333 |
Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 |
phosphorylation |
Ser106 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01334 |
Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 |
phosphorylation |
Ser107 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01335 |
Mitotic checkpoint serine/threonine-protein kinase BUB1 beta |
phosphorylation |
Ser670 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01336 |
Protein diaphanous homolog 1 |
phosphorylation |
Ser22 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01337 |
Protein arginine N-methyltransferase 3 |
phosphorylation |
Ser25 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01338 |
Protein arginine N-methyltransferase 3 |
phosphorylation |
Ser27 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01339 |
H/ACA ribonucleoprotein complex subunit DKC1 |
phosphorylation |
Ser451 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01340 |
H/ACA ribonucleoprotein complex subunit DKC1 |
phosphorylation |
Ser455 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01341 |
Eukaryotic translation initiation factor 5B |
phosphorylation |
Ser186 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01342 |
Eukaryotic translation initiation factor 5B |
phosphorylation |
Ser190 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01343 |
Eukaryotic translation initiation factor 5B |
phosphorylation |
Ser113 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01344 |
Pre-mRNA-processing factor 40 homolog A |
phosphorylation |
Ser888 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01345 |
Tumor necrosis factor receptor superfamily member 21 |
phosphorylation |
Ser541 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01346 |
U5 small nuclear ribonucleoprotein 200 kDa helicase |
phosphorylation |
Ser225 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01347 |
Ribosomal L1 domain-containing protein 1 |
phosphorylation |
Ser427 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01348 |
Tight junction protein ZO-3 |
phosphorylation |
Ser112 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01349 |
Tight junction protein ZO-3 |
phosphorylation |
Ser327 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01350 |
Supervillin |
phosphorylation |
Ser245 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|